Metraipolis › archive › dc_2ed7580b89f5

Cabotegravir and rilpivirine for treatment of HIV infection in Africa: week 96 results from the phase 3b randomized, open-label, noninferiority CARES trial — Europe PMC PMID:41188524

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41188524
DOI
10.1038/s41591-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-11-08T19:37:57.404Z
SHA-256 of the archived text
80644a01c9fb0c3d448d9f0ef57ff36b8bb405c51010eaddbd583e8bf92eb10d
Stable URL of this page
https://metraipolis.com/documento/dc_2ed7580b89f5

How to cite

Cabotegravir and rilpivirine for treatment of HIV infection in Africa: week 96 results from the phase 3b randomized, open-label, noninferiority CARES trial — Europe PMC PMID:41188524 — Europe PMC (en), https://europepmc.org/article/MED/41188524 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2ed7580b89f5 (Metraipolis archive dc_2ed7580b89f5, sha256 80644a01c9fb0c3d448d9f0ef57ff36b8bb405c51010eaddbd583e8bf92eb10d)
BibTeX
@misc{dc2ed7580b89f5,
  title = {Cabotegravir and rilpivirine for treatment of HIV infection in Africa: week 96 results from the phase 3b randomized, open-label, noninferiority CARES trial — Europe PMC PMID:41188524},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41188524},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2ed7580b89f5; sha256 80644a01c9fb0c3d448d9f0ef57ff36b8bb405c51010eaddbd583e8bf92eb10d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41188524. Agents can read the archived copy with the MCP tool read_document.